Insurance
Insurance
Reinsurance
Reinsurance
Product Family
Product Family
Claims
Claims
Risk Consulting
Risk Consulting
Resources & Tools
Resources & Tools
Resources and Tools
About AXA XL
About AXA XL
Media Center
Media Center
Get In Touch
Get In Touch

XL Capital prices issue of preference ordinary shares
HAMILTON, BERMUDA - November 12, 2002
HAMILTON, Bermuda (November 13, 2002) - XL Capital Ltd (“XL”) (NYSE: XL) announced today that it has agreed to sell 10,000,000 7 5/8% Series B preference ordinary shares pursuant to XL's currently effective shelf registration statement (plus up to an additional 1,500,000 preference shares issuable upon exercise of the underwriters’ overallotment option). The preference shares are being issued at an initial price to the public of $25.00 per share and will not be exchangeable for or convertible into ordinary shares of XL. The managing underwriters for XL’s preference share offering are Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated, as joint book-runners.The net proceeds from the sale of the preference shares will be used for general corporate purposes.XL Capital Ltd, through its operating subsidiaries, is a leading provider of insurance and reinsurance coverages and financial products to industrial, commercial and professional service firms, insurance companies, and other enterprises on a worldwide basis. As of September 30, 2002, XL Capital Ltd had consolidated assets of approximately $34.1 billion and consolidated shareholders' equity of approximately $5.9 billion. More information about XL Capital Ltd is available at www.xlgroup.com.This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the preference shares or any other securities, nor will there be any sale of the preference shares or any other securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.This press release contains forward-looking statements which involve inherent risks and uncertainties. Statements that are not historical facts, including statements about XL’s beliefs, plans or expectations, are forward-looking statements. These statements are based on current plans, estimates and expectations. Actual results may differ materially from those projected in such forward-looking statements and therefore you should not place undue reliance on them. A non-exclusive list of other important factors that could cause actual results to differ materially from those in such forward-looking statements is set forth in XL’s most recent annual report on Form 10-K, quarterly report on Form 10-Q and XL’s other documents on file with the Securities and Exchange Commission. XL undertakes no obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future developments or otherwise.THIS AXA WEBSITE USES COOKIES
AXA XL, as a controller, uses cookies to provide its service, improve user experience, measure audience engagement, and interact with users’ social network accounts. We won't set optional cookies unless you enable them. You can disable them at any time.
For more detailed information on the cookies used for this website, you can read our Cookie Policy.